Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Catheter Cardiovasc Interv. 2018 Oct 9;93(7):E385–E390. doi: 10.1002/ccd.27915

Table 1: Demographics, risk factors and hospital characteristics in patients who underwent TAVI and SAVR.

TAVI (n=33,690) SAVR (n=202,110) p-value
Admission year 2012 6320 65805
Admission year 2013 11420 68405
Admission year 2014 15950 67900
Age (mean ± standard deviation) 81 ± 9 68 ± 13 <0.001
Male 50.6% 64.5% <0.001
Race White 81.4% 77.9% <0.001
Hypertension 79.4% 73.2% <0.001
Diabetes 34.5% 30.0% <0.001
Dyslipidemia 64.0% 58.9% <0.001
Current smoking 3.4% 10.5% <0.001
Obesity 14.8% 20.3% <0.001
Coronary artery disease 29.5% 42.8% <0.001
Prior PCI 18.3% 8.0% <0.001
Prior CABG 20.7% 4.4% <0.001
Prior stroke/TIA 10.0% 6.2% <0.001
Anemia 26.5% 19.4% <0.001
Renal failure 35.4% 15.9% <0.001
Chronic pulmonary disease 33.6% 20.9% <0.001
Peripheral vascular disease 29.9% 21.0% <0.001
Atrial fibrillation 43.2% 44.9% 0.02
Hospital location/status <0.001
 Rural hospital 0.7% 2.3%
 Urban teaching hospital 89.2% 74.6%
 Urban nonteaching hospital 10.1% 23.1%
Hospital size <0.001
 Small 4.4% 6.8%
 Medium 16.9% 20.4%
 Large 78.7% 72.8%
Hospital region 0.04
 Midwest 22.7% 24.9%
 Northeast 26.5% 22.8%
 South 33.3% 32.5%
 West 17.5% 19.8%
Length of stay (days; median [IQR]) 6 [4–9] 8 [5–12] <0.001
Cost ($; median [IQR]) 195,620 [142,667–274,253] 161,840 [113,168–246,396] <0.001

CABG: coronary artery bypass grafting, IQR: interquartile range, PCI: percutaneous coronary intervention, SAVR: surgical aortic valve replacement, TAVI: trans-catheter aortic valve implantation, TIA: transient ischemic attack,